Xyphos Biosciences
CAR-T Immunotherapy
Xyphos is committed to the mission of developing a flexible and controllable CAR-T cell therapy to provide patients with the possibility of a durable cure from cancer.
Read more here
Pylum Biosciences
Microbiome/Anti-bacterial
Pylum Biosicences has developed and patented an Avidocin™ platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens.
Read more here
